An international consortium has achieved a major breakthrough in the diagnosis of neurological diseases. In a recent ...

Scientists have discovered a new quantitative biomarker in lumbar fluid that is helping doctors to diagnose Parkinson's ...

May aid in the diagnosis of prion disease. RT-QuIC identifies the disease-causing agent. Total TAU and 14-3-3γ are indirect markers of neurodegenerative diseases. Assumes that the patient has a ...

Can a spinal fluid test diagnose Parkinson’s? Researchers have identified DOPA decarboxylase as a key biomarker that separates Parkinson’s and Lewy body dementia from other forms of cognitive decline.

Mantle cell lymphoma (MCL) is an aggressive neoplasm that is incurable by standard therapy. Patients often present with high-stage disease (Stages III–IV) and frequently have involvement at multiple ...

CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), today announces a new payer coverage agreement with Highmark, effective April 1, ...

As many as one quarter of all adults over the age of 60 experience age-related cognitive decline. This cognitive decline may be due to many factors, such as problems with sleep, the loss of neurons, ...

A pharmacokinetic (PK) study of AC480 administered twice daily in patients with surgically resectable, recurrent malignant glioma (MG) not on enzyme-inducing antiepileptic drug (EIAED). Background: ...

Diagnosing brain diseases such as Parkinson’s disease and dementia can be very difficult, especially in the early stages.

Since the characterization of prions in the 1970s, there has been progress in diagnostic testing, which at one time required brain specimens from biopsy or autopsy, with surgical risks for the patient ...

A CSF leak occurs when cerebrospinal fluid (CSF) escapes from the protective layer surrounding the brain and spinal cord. This is a serious condition that can cause headaches, seizures, or meningitis.